pembrolizumab,cisplatin,gemcitabine,pemetrexed,Nivolumab,Ipilimumab
merck,BMS
['congrat']
 congrats ! this will go a long way for patients, and we are lucky to have you !
MD @mcgillu | Building https://t.co/IKx494EgPR | Research, Innovation, & Magic